Ying Zhao1, Nian Xiong, Yang Liu, Yanhong Zhou, Nuomin Li, Hong Qing, Zhicheng Lin. 1. Department of Psychiatry, Harvard Medical School & Laboratory of Psychiatric Neurogenomics, Division of Alcohol & Drug Abuse, McLean Hospital, Mailstop 318, 115 Mill Street, Belmont, MA 02478, USA.
Abstract
AIM: Since previous functional studies of short haplotypes and polymorphic sites of SLC6A3 have shown variant-dependent and drug-sensitive promoter activity, this study aimed to understand whether a large SLC6A3 regulatory region, containing these small haplotypes and polymorphic sites, can display haplotype-dependent promoter activity in a drug-sensitive and pathway-related manner. MATERIALS & METHODS: By creating and using a single copy number luciferase-reporter vector, we examined regulation of two different SLC6A3 haplotypes (A and B) of the 5´ 18-kb promoter and two known downstream regulatory variable number tandem repeats by 17 drugs in four different cellular models. RESULTS: The two regulatory haplotypes displayed up to 3.2-fold difference in promoter activity. The regulations were drug selective (37.5% of the drugs showed effects), and both haplotype and cell type dependent. Pathway analysis revealed at least 13 main signaling hubs targeting SLC6A3, including histone deacetylation, AKT, PKC and CK2 α-chains. CONCLUSION: SLC6A3 may be regulated via either its promoter or the variable number tandem repeats independently by specific signaling pathways and in a haplotype-dependent manner. Furthermore, we have developed the first pathway map for SLC6A3 regulation. These findings provide a framework for understanding complex and variant-dependent regulations of SLC6A3.
AIM: Since previous functional studies of short haplotypes and polymorphic sites of SLC6A3 have shown variant-dependent and drug-sensitive promoter activity, this study aimed to understand whether a large SLC6A3 regulatory region, containing these small haplotypes and polymorphic sites, can display haplotype-dependent promoter activity in a drug-sensitive and pathway-related manner. MATERIALS & METHODS: By creating and using a single copy number luciferase-reporter vector, we examined regulation of two different SLC6A3 haplotypes (A and B) of the 5´ 18-kb promoter and two known downstream regulatory variable number tandem repeats by 17 drugs in four different cellular models. RESULTS: The two regulatory haplotypes displayed up to 3.2-fold difference in promoter activity. The regulations were drug selective (37.5% of the drugs showed effects), and both haplotype and cell type dependent. Pathway analysis revealed at least 13 main signaling hubs targeting SLC6A3, including histone deacetylation, AKT, PKC and CK2 α-chains. CONCLUSION:SLC6A3 may be regulated via either its promoter or the variable number tandem repeats independently by specific signaling pathways and in a haplotype-dependent manner. Furthermore, we have developed the first pathway map for SLC6A3 regulation. These findings provide a framework for understanding complex and variant-dependent regulations of SLC6A3.
Authors: Christopher H van Dyck; Robert T Malison; Leslie K Jacobsen; John P Seibyl; Julie K Staley; Marc Laruelle; Ronald M Baldwin; Robert B Innis; Joel Gelernter Journal: J Nucl Med Date: 2005-05 Impact factor: 10.057
Authors: Ashley L Green; Muhammad M Hossain; Siew C Tee; Helmut Zarbl; Grace L Guo; Jason R Richardson Journal: Neurochem Res Date: 2015-05-12 Impact factor: 3.996
Authors: Nian Xiong; Nuomin Li; Eden Martin; Jinlong Yu; Jie Li; Jing Liu; David Yue-Wei Lee; Ole Isacson; Jeffery Vance; Hong Qing; Tao Wang; Zhicheng Lin Journal: Neurotherapeutics Date: 2016-07 Impact factor: 7.620
Authors: James L Kennedy; Nian Xiong; Jinlong Yu; Clement C Zai; Jennie G Pouget; Jie Li; Kefu Liu; Hong Qing; Tao Wang; Eden Martin; Deborah L Levy; Zhicheng Lin Journal: Schizophr Bull Date: 2015-12-26 Impact factor: 9.306
Authors: Maarten E A Reith; Sandhya Kortagere; Corinde E Wiers; Hui Sun; Manju A Kurian; Aurelio Galli; Nora D Volkow; Zhicheng Lin Journal: Mol Psychiatry Date: 2021-10-14 Impact factor: 13.437
Authors: Clara L Essmann; Katie R Ryan; Muna Elmi; Kimberley Bryon-Dodd; Andrew Porter; Andrew Vaughan; Rachel McMullan; Stephen Nurrish Journal: PLoS One Date: 2018-09-21 Impact factor: 3.240
Authors: Kefu Liu; Juan Zhao; Chunnuan Chen; Jie Xu; Richard L Bell; Frank S Hall; George F Koob; Nora D Volkow; Hong Qing; Zhicheng Lin Journal: EBioMedicine Date: 2020-10-21 Impact factor: 8.143